Elevance Health, Inc. - Laporan Laba Rugi (TTM)

Elevance Health, Inc.
IT ˙ BIT
€ 260.00 0.00 (0.00%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Elevance Health, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 117,449 121,868 124,632 129,219 133,883 138,643 144,353 149,134 153,251 156,599 160,676 165,716 168,626 171,340 171,745 171,719 174,015 176,810 183,124 189,254
Change (%) 3.76 2.27 3.68 3.61 3.56 4.12 3.31 2.76 2.18 2.60 3.14 1.76 1.61 0.24 -0.02 1.34 1.61 3.57 3.35
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 85,340 88,045 90,255 95,471 99,195 102,571 107,177 111,209 113,985 116,642 119,197 121,851 123,191 124,330 124,090 123,058 125,401 127,567 132,333 138,467
Change (%) 3.17 2.51 5.78 3.90 3.40 4.49 3.76 2.50 2.33 2.19 2.23 1.10 0.92 -0.19 -0.83 1.90 1.73 3.74 4.64
% of Revenue 72.66 72.25 72.42 73.88 74.09 73.98 74.25 74.57 74.38 74.48 74.18 73.53 73.06 72.56 72.25 71.66 72.06 72.15 72.26 73.16
Gross Operating Profit 32,109 33,823 34,377 33,748 34,688 36,072 37,176 37,925 39,266 39,957 41,479 43,865 45,435 47,010 47,655 48,661 48,614 49,243 50,791 50,787
Change (%) 5.34 1.64 -1.83 2.79 3.99 3.06 2.01 3.54 1.76 3.81 5.75 3.58 3.47 1.37 2.11 -0.10 1.29 3.14 -0.01
% of Revenue 27.34 27.75 27.58 26.12 25.91 26.02 25.75 25.43 25.62 25.52 25.82 26.47 26.94 27.44 27.75 28.34 27.94 27.85 27.74 26.84
SG&A 23,013 25,202 25,675 25,839 26,357 26,604 27,590 28,496 29,605 30,728 31,749 33,539 35,718 36,236 36,666 37,407 37,383 39,466 41,038 41,442
Change (%) 9.51 1.88 0.64 2.00 0.94 3.71 3.28 3.89 3.79 3.32 5.64 6.50 1.45 1.19 2.02 -0.06 5.57 3.98 0.98
% of Revenue 19.59 20.68 20.60 20.00 19.69 19.19 19.11 19.11 19.32 19.62 19.76 20.24 21.18 21.15 21.35 21.78 21.48 22.32 22.41 21.90
R&D
Change (%)
% of Revenue
OpEx 108,704 113,608 116,288 121,665 125,950 129,616 135,257 140,271 144,245 148,137 151,819 156,318 159,824 161,451 161,522 161,172 163,401 167,613 173,990 180,513
Change (%) 4.51 2.36 4.62 3.52 2.91 4.35 3.71 2.83 2.70 2.49 2.96 2.24 1.02 0.04 -0.22 1.38 2.58 3.80 3.75
% of Revenue 92.55 93.22 93.31 94.15 94.07 93.49 93.70 94.06 94.12 94.60 94.49 94.33 94.78 94.23 94.05 93.86 93.90 94.80 95.01 95.38
Operating Income 8,745 8,260 8,344 7,554 7,933 9,027 9,096 8,863 9,006 8,462 8,857 9,398 8,802 9,889 10,223 10,547 10,614 9,197 9,134 8,741
Change (%) -5.55 1.02 -9.47 5.02 13.79 0.76 -2.56 1.61 -6.04 4.67 6.11 -6.34 12.35 3.38 3.17 0.64 -13.35 -0.69 -4.30
% of Revenue 7.45 6.78 6.69 5.85 5.93 6.51 6.30 5.94 5.88 5.40 5.51 5.67 5.22 5.77 5.95 6.14 6.10 5.20 4.99 4.62
Interest Expense -782 -785 -783 -787 -790 -802 -811 -814 -826 -855 -905 -958 -1,004 -1,030 -1,044 -1,063 -1,104 -1,185 -1,264 -1,325
Change (%) 0.38 -0.25 0.51 0.38 1.52 1.12 0.37 1.47 3.51 5.85 5.86 4.80 2.59 1.36 1.82 3.86 7.34 6.67 4.83
% of Revenue -0.67 -0.64 -0.63 -0.61 -0.59 -0.58 -0.56 -0.55 -0.54 -0.55 -0.56 -0.58 -0.60 -0.60 -0.61 -0.62 -0.63 -0.67 -0.69 -0.70
Net Income 4,955 4,572 4,714 4,231 5,518 6,158 6,228 6,072 6,166 5,894 6,094 6,441 5,996 5,987 6,244 6,691 6,418 5,980 5,917 5,360
Change (%) -7.73 3.11 -10.25 30.42 11.60 1.14 -2.50 1.55 -4.41 3.39 5.69 -6.91 -0.15 4.29 7.16 -4.08 -6.82 -1.05 -9.41
% of Revenue 4.22 3.75 3.78 3.27 4.12 4.44 4.31 4.07 4.02 3.76 3.79 3.89 3.56 3.49 3.64 3.90 3.69 3.38 3.23 2.83

Source: Capital IQ

Other Listings
MX:ELV
GB:0HG8 US$ 310.52
US:ELV US$ 313.64
AT:ELV
DE:A58 € 263.40
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista